<turbo-stream action="append" target="news"><template>  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-danger bg-red-100">
          Negativ
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">Reuters</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 20 Tagen</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.reuters.com/world/china/roche-chairman-likens-us-tariff-policy-blackmail-2026-06-04/">Roche chairman likens US tariff policy to &#39;blackmail&#39;</a>
    </div>

      <div class="me-0 me-md-5">
        The chairman of Swiss pharmaceutical giant Roche ​hit out at U.S. tariff policies on ‌Thursday, likening them to &quot;blackmail&quot;, and said protectionism by the United States and China was the firm&#39;s biggest ​geopolitical concern.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-danger bg-red-100">
          Negativ
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">WSJ</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.wsj.com/health/pharma/roche-halts-development-of-drug-candidate-for-muscle-diseases-chugai-says-acabc236">Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says</a>
    </div>

      <div class="me-0 me-md-5">
        The company discontinued developing emugrobart after two studies showed the drug didn&#39;t achieve intended outcomes.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/roche-holding-ag-aktie-unter-druck-diagnostik-schwaeche-und/68962812">Die Roche Holding AG Aktie (ISIN: CH0012032048) gerät an der SIX Swiss Exchange in CHF unter Druck durch post-pandemische Effekte im Diagnostiksegment und den Stopp des Emugrobart-Programms bei Genentech. DACH-Investoren prüfen, ob die starke Pharma-Pipeline dies ausgleicht. Frische Berichte vom 19. und 20. März 2026 beleuchten die Herausforderungen und Chancen.</a>
    </div>

      <div class="me-0 me-md-5">
        Roche Holding AG Aktie unter Druck: Diagnostik-Schwäche und Pipeline-Abbruch belasten Kurs an der SIX Swiss Exchange
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/roche-holding-ag-aktie-unter-druck-diagnostik-schwaeche-und/68962807">Die Roche Holding AG Aktie (ISIN: CH0012032048) gerät durch post-pandemische Effekte im Diagnostikbereich und den Abbruch des Emugrobart-Programms unter Druck. DACH-Investoren prüfen, ob die starke Pharma-Pipeline dies ausgleicht. Frische Berichte vom 19. und 20. März 2026 beleuchten die Herausforderungen.</a>
    </div>

      <div class="me-0 me-md-5">
        Roche Holding AG Aktie unter Druck: Diagnostik-Schwäche und Pipeline-Abbruch belasten Kurs an der SIX Swiss Exchange
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/roche-holding-ag-aktie-unter-druck-diagnostik-schwaeche-und/68963179">Die Roche Holding AG Aktie (ISIN: CH0012032048) gerät an der SIX Swiss Exchange in CHF unter Druck durch post-pandemische Effekte im Diagnostiksegment und den Abbruch des Emugrobart-Programms. DACH-Investoren prüfen, ob die starke Pharma-Pipeline dies ausgleicht. Frische Berichte vom 19. und 20. März 2026 beleuchten die Herausforderungen.</a>
    </div>

      <div class="me-0 me-md-5">
        Roche Holding AG Aktie unter Druck: Diagnostik-Schwäche und Pipeline-Abbruch belasten Kurs an der SIX Swiss Exchange
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/roche-holding-ag-aktie-unter-druck-diagnostik-schwaeche-und/68960284">Die Roche Holding AG Aktie (ISIN: CH0012032048) gerät an der SIX Swiss Exchange in CHF unter Druck durch post-pandemische Effekte im Diagnostiksegment und den Abbruch des Emugrobart-Programms. DACH-Investoren prüfen, ob die starke Pharma-Pipeline dies ausgleicht. Frische Berichte vom 19. und 20. März 2026 beleuchten die Herausforderungen.</a>
    </div>

      <div class="me-0 me-md-5">
        Roche Holding AG Aktie unter Druck: Diagnostik-Schwäche und Pipeline-Abbruch belasten Kurs an der SIX Swiss Exchange
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">AD HOC NEWS</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.ad-hoc-news.de/boerse/news/ueberblick/roche-holding-ag-aktie-unter-druck-diagnostik-schwaeche-und/68946474">Die Roche Holding AG Aktie (ISIN: CH0012032048) notiert an der SIX Swiss Exchange in CHF unter Druck durch Schwächen im Diagnostiksegment und den Stopp der Emugrobart-Entwicklung. Frische Berichte vom 19. und 20. März 2026 heben regulatorische Hürden und Kostendruck hervor. DACH-Investoren prüfen die Resilienz des Pharma-Riesen genau.</a>
    </div>

      <div class="me-0 me-md-5">
        Roche Holding AG Aktie unter Druck: Diagnostik-Schwäche und Pipeline-Anpassungen belasten Kurs an der SIX Swiss Exchange
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

  <div class="row mb-4 py-2 news-box">
  <div class="col-12 col-md-8 col-lg-9 order-md-1 order-2">
    <div class="news-box__info-line mb-2">
        <span class="me-2 new badge text-success bg-green-100">
          Positiv
        </span>
        <div class="me-2"><a class="text-gray" data-turbo-frame="_top" href="/aktien/Roche-CH1499059983">Roche</a></div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="me-2 text-gray">WSJ</div>
        <div class="me-2 text-gray text-size-10">●</div>
        <div class="text-gray">vor 3 Monaten</div>
    </div>

    <div class="mb-2">
      <a target="_blank" rel="nofollow" href="https://www.wsj.com/health/pharma/roche-bets-splits-in-obesity-market-will-open-door-to-new-entrants-05213992">Roche Bets Splits in Obesity Market Will Open Door to New Entrants</a>
    </div>

      <div class="me-0 me-md-5">
        EXCLUSIVE: The pharmaceutical giant is re-entering the obesity market and aims to become a top-three player, rivaling the likes of Eli Lilly and Novo Nordisk.
      </div>
  </div>

  <div class="col-12 col-md-4 col-lg-3 order-md-2 order-1">
  </div>
</div>

</template></turbo-stream><turbo-stream action="replace" target="link"><template><div id="link">
    <a class="btn btn-outline-primary btn--small" data-turbo-stream="" href="/news/Roche-CH1499059983/load_more?page=4">
      Mehr Neuigkeiten anzeigen
      <i class="fa fa-arrow-down fa-fw"></i>
</a></div>
</template></turbo-stream>